15
Participants
Start Date
April 10, 1996
Primary Completion Date
May 11, 2003
Study Completion Date
May 11, 2003
antineoplaston A10, antineoplaston AS2-1 (ANP)
"Patients with metastatic or unresectable Colon Cancer will receive Antineoplaston therapy (Atengenal + Astugenal).~The daily doses of A10 and AS2-1 are divided into six infusions, which are given at 4-hourly intervals. Each infusion starts with infusion of A10 and is immediately followed by infusion of AS2-1."
Burzynski Clinic, Houston
Lead Sponsor
Burzynski Research Institute
OTHER